Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ALEXION PHARMACEUTICALS, INC.

(ALXN)
  Report
SummaryQuotesChartsNewsRatingsCompanyFinancials 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about ALEXION PHARMACEUTICALS, INC.
10/11ALEXION PHARMACEUTICALS : Canada Seeks Leave To Appeal To The Supreme Court In PMPRB Exces..
AQ
10/05Alexion Pharmaceuticals, Inc. completed the acquisition of remaining majority stake in ..
CI
09/29AstraZeneca's Alexion to Advance and Accelerate Ongoing Phase III Clinical Development ..
CI
09/29Alexion Pharmaceuticals, Inc. agreed to acquire remaining majority stake in Caelum Bios..
CI
08/28ALEXION PHARMACEUTICALS : FCA Remits Pricing Decision On ALEXION'S SOLIRIS To PMPRB
AQ
08/23ALEXION PHARMACEUTICALS : Update on CHAMPION-ALS Phase III trial of Ultomiris in amyotroph..
AQ
08/20Alexion Discontinues CHAMPION-ALS
CI
08/06ALEXION PHARMACEUTICALS : Canadian Drug Price Review Board Reined In
AQ
08/05"THIS COURT DOES NOT SIGN BLANK CHEQ : Federal Court Of Appeal Reverses Canada's Patented ..
AQ
07/22ALEXION PHARMACEUTICALS : Termination of Material Definitive Agreements (Form 8-K)
PU
07/22Alexion Pharmaceuticals, Inc. Announces Board Cessations
CI
07/21ALEXION PHARMACEUTICALS, INC.(NASDAQ : ALXN) dropped from S&P 500 EQUAL WEIGHTED
CI
07/21ALEXION PHARMACEUTICALS, INC.(NASDAQ : ALXN) dropped from S&P TMI Index
CI
07/21ALEXION PHARMACEUTICALS, INC.(NASDAQ : ALXN) dropped from S&P Global 1200
CI
07/21ALEXION PHARMACEUTICALS, INC.(NASDAQ : ALXN) dropped from S&P Global BMI Index
CI
More most relevant news
All news about ALEXION PHARMACEUTICALS, INC.
10/11ALEXION PHARMACEUTICALS : Canada Seeks Leave To Appeal To The Supreme Court In PMPRB Exces..
AQ
10/05Alexion Pharmaceuticals, Inc. completed the acquisition of remaining majority stake in ..
CI
09/29OCULAR THERAPEUTIX : Announces appointment of karen-leigh edwards as senior vice president..
AQ
09/29AstraZeneca's Alexion to Advance and Accelerate Ongoing Phase III Clinical Development ..
CI
09/29Alexion Pharmaceuticals, Inc. agreed to acquire remaining majority stake in Caelum Bios..
CI
08/30ASTRAZENECA : to Mandate COVID-19 Shots for US Staff
MT
08/28ALEXION PHARMACEUTICALS : FCA Remits Pricing Decision On ALEXION'S SOLIRIS To PMPRB
AQ
08/26ASTRAZENECA : Rare Disease Drug Improves Copper Mobilization in Late-Stage Study
MT
08/23ALEXION PHARMACEUTICALS : Update on CHAMPION-ALS Phase III trial of Ultomiris in amyotroph..
AQ
08/20FTSE : Consumer staples, financials lift FTSE 100 after worst week since February
RE
More news
News in other languages on ALEXION PHARMACEUTICALS, INC.
11/12Astrazeneca tombe dans le rouge au 3e timestre, malgré le vaccin
08/30AstraZeneca va rendre obligatoires les injections de COVID-19 pour le personnel américa..
08/26Un médicament d'AstraZeneca contre les maladies rares améliore la mobilisation du cuivr..
08/20AKTIEN EUROPA SCHLUSS : Freundlicher Wochenausklang dank US-Rückenwind
08/20AKTIEN EUROPA : Anleger bleiben vorsichtig
08/20ASTRAZENECA : fin d'un essai non concluant sur la SLA
08/20Astrazeneca mit Covid-19-Antikörper erfolgreich - weitere Arznei floppt
07/29ASTRAZENECA : Les ventes du vaccin contre le COVID bondissent au T2
07/29Corona-Impfung verleiht Astrazeneca Schwung
07/29ASTRAZENECA : plus de 1 milliard de dollars engrangés avec le vaccin
More news
Analyst Recommendations on ALEXION PHARMACEUTICALS, INC.
05/05ALEXION PHARMACEUTICALS : Oppenheimer Upgrades Alexion Pharmaceuticals to Outperform From ..
MT
05/03ALEXION PHARMACEUTICALS : SVB Leerink Adjusts Alexion Pharmaceuticals PT to $173 From $156..
MT
03/23ALEXION PHARMACEUTICALS : SVB Leerink Downgrades Alexion Pharmaceuticals to Market Perform..
MT
02/05ALEXION PHARMACEUTICALS : SVB Leerink Adjusts Price Target on Alexion Pharmaceuticals to $..
MT
01/08ALEXION PHARMACEUTICALS : Raymond James Downgrades Alexion Pharmaceuticals to Market Perfo..
MT
More recommendations
Press releases
10/11ALEXION PHARMACEUTICALS : Canada Seeks Leave To Appeal To The Supreme Court In PMPRB Exces..
AQ
09/29OCULAR THERAPEUTIX : Announces appointment of karen-leigh edwards as senior vice president..
AQ
08/28ALEXION PHARMACEUTICALS : FCA Remits Pricing Decision On ALEXION'S SOLIRIS To PMPRB
AQ
08/23ALEXION PHARMACEUTICALS : Update on CHAMPION-ALS Phase III trial of Ultomiris in amyotroph..
AQ
08/06ALEXION PHARMACEUTICALS : Canadian Drug Price Review Board Reined In
AQ
More press releases